✦ LIBER ✦
Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme
✍ Scribed by Lieke H. van der Helm; Canan Alhan; Pierre W. Wijermans; Marinus van Marwijk Kooy; Ron Schaafsma; Bart J. Biemond; Aart Beeker; Mels Hoogendoorn; Bastiaan P. van Rees; Okke de Weerdt; Jurgen Wegman; Ward J. Libourel; Sylvia A. Luykx-de Bakker; Monique C. Minnema; Rolf E. Brouwer; Fransien Croon-de Boer; Matthijs Eefting; Kon-Siong G. Jie; Arjan A. van de Loosdrecht; Jan Koedam; Nic J. G. M Veeger; Edo Vellenga; Gerwin Huls
- Book ID
- 108677464
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 205 KB
- Volume
- 155
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.